WallStSmart

Lineage, Inc. Common Stock (LINE)vsUMH Properties Inc (UMH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lineage, Inc. Common Stock generates 1915% more annual revenue ($5.36B vs $265.94M). UMH leads profitability with a 11.0% profit margin vs -2.7%. UMH earns a higher WallStSmart Score of 51/100 (C-).

LINE

Avoid

34

out of 100

Grade: F

Growth: 4.0Profit: 3.0Value: 5.0Quality: 3.0
Piotroski: 2/9Altman Z: 0.67

UMH

Buy

51

out of 100

Grade: C-

Growth: 5.3Profit: 5.5Value: 6.7Quality: 6.5
Piotroski: 4/9Altman Z: 1.09
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for LINE.

UMHUndervalued (+62.8%)

Margin of Safety

+62.8%

Fair Value

$43.40

Current Price

$15.26

$28.14 discount

UndervaluedFair: $43.40Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LINE1 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

UMH2 strengths · Avg: 8.0/10
PEG RatioValuation
0.728/10

Growing faster than its price suggests

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

Areas to Watch

LINE4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.4%4/10

0.4% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Operating MarginProfitability
3.3%3/10

Operating margin of 3.3%

Debt/EquityHealth
1.013/10

Elevated debt levels

UMH4 concerns · Avg: 2.5/10
Market CapQuality
$1.28B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
3.3%3/10

ROE of 3.3% — below average capital efficiency

P/E RatioValuation
150.2x2/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
-54.2%2/10

Earnings declined 54.2%

Comparative Analysis Report

WallStSmart Research

Bull Case : LINE

The strongest argument for LINE centers on Price/Book.

Bull Case : UMH

The strongest argument for UMH centers on PEG Ratio, Price/Book. PEG of 0.72 suggests the stock is reasonably priced for its growth.

Bear Case : LINE

The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.

Bear Case : UMH

The primary concerns for UMH are Market Cap, Return on Equity, P/E Ratio. A P/E of 150.2x leaves little room for execution misses.

Key Dynamics to Monitor

LINE profiles as a turnaround stock while UMH is a value play — different risk/reward profiles.

UMH is growing revenue faster at 7.6% — sustainability is the question.

UMH generates stronger free cash flow (17M), providing more financial flexibility.

Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

UMH scores higher overall (51/100 vs 34/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lineage, Inc. Common Stock

REAL ESTATE · REIT - INDUSTRIAL · USA

Lineage, Inc. (Ticker: LINE) is an innovative biotechnology company specializing in regenerative medicine, with a focus on developing state-of-the-art cell therapies for conditions such as ocular diseases, spinal cord injuries, and various cancers. Leveraging its proprietary technologies and strong strategic partnerships, Lineage aims to revolutionize patient care with pioneering therapeutic solutions. The company’s dedication to advancing its diverse product pipeline and accelerating clinical trials positions it as a compelling investment prospect for institutional investors looking to engage at the cutting edge of healthcare advancements.

Visit Website →

UMH Properties Inc

REAL ESTATE · REIT - RESIDENTIAL · USA

UMH Properties, Inc., which was organized in 1968, is a publicly owned REIT that owns and operates 124 manufactured home communities containing approximately 23,400 developed lots.

Want to dig deeper into these stocks?